NCT02308839View on ClinicalTrials.gov

GORE® EXCLUDER® Endoprosthesis French Mandatory Registry

CompletedOBSERVATIONAL
Enrollment

181

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 26, 2018

Study Completion Date

October 5, 2018

Conditions
Abdominal Aortic Aneurysm
Interventions
DEVICE

GORE® EXCLUDER® Endoprosthesis

Endovascular therapy to treat abdominal aortic aneurysms

Trial Locations (1)

21034

Centre Hospitalier de Dijon, Dijon

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT02308839 - GORE® EXCLUDER® Endoprosthesis French Mandatory Registry | Biotech Hunter | Biotech Hunter